1,538
Views
7
CrossRef citations to date
0
Altmetric
Articles

Valuations of experimental designs in proteomic biomarker experiments and traditional randomised controlled trials

, &
Pages 157-172 | Received 21 Nov 2014, Accepted 06 Oct 2015, Published online: 16 Dec 2015

Figures & data

FIGURE 1. Three versions of trial design within the overall RCT design framework for testing different treatments. The split-person design could, for instance concern treatments distributed as an ointment where each trial subject gets two interventions one on different sides of their bodies (adapted from Hackshaw Citation2009, p. 59).

FIGURE 1. Three versions of trial design within the overall RCT design framework for testing different treatments. The split-person design could, for instance concern treatments distributed as an ointment where each trial subject gets two interventions one on different sides of their bodies (adapted from Hackshaw Citation2009, p. 59).

FIGURE 2. A schematic figure of the Microarray in Node-Negative Disease May Avoid Chemotherapy (MINDACT) trial design (adapted from Mandrekar & Sargent Citation2009, p. 4031).

FIGURE 2. A schematic figure of the Microarray in Node-Negative Disease May Avoid Chemotherapy (MINDACT) trial design (adapted from Mandrekar & Sargent Citation2009, p. 4031).